First Long Island Investors LLC boosted its holdings in UnitedHealth Group (NYSE:UNH) by 1.1% during the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 26,401 shares of the healthcare conglomerate’s stock after purchasing an additional 300 shares during the period. First Long Island Investors LLC’s holdings in UnitedHealth Group were worth $5,650,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other hedge funds and other institutional investors have also modified their holdings of UNH. KBC Group NV increased its position in shares of UnitedHealth Group by 4.7% during the third quarter. KBC Group NV now owns 323,799 shares of the healthcare conglomerate’s stock valued at $63,416,000 after purchasing an additional 14,672 shares during the period. Toronto Dominion Bank increased its position in shares of UnitedHealth Group by 12.6% during the fourth quarter. Toronto Dominion Bank now owns 432,508 shares of the healthcare conglomerate’s stock valued at $95,350,000 after purchasing an additional 48,565 shares during the period. GWM Advisors LLC increased its position in shares of UnitedHealth Group by 20.3% during the fourth quarter. GWM Advisors LLC now owns 9,297 shares of the healthcare conglomerate’s stock valued at $2,090,000 after purchasing an additional 1,571 shares during the period. Norinchukin Bank The increased its position in shares of UnitedHealth Group by 2.7% during the third quarter. Norinchukin Bank The now owns 180,773 shares of the healthcare conglomerate’s stock valued at $35,405,000 after purchasing an additional 4,838 shares during the period. Finally, Global Financial Private Capital LLC increased its position in shares of UnitedHealth Group by 13.7% during the fourth quarter. Global Financial Private Capital LLC now owns 18,386 shares of the healthcare conglomerate’s stock valued at $4,053,000 after purchasing an additional 2,212 shares during the period. 87.11% of the stock is currently owned by institutional investors.
UnitedHealth Group stock opened at $244.64 on Friday. The company has a current ratio of 0.71, a quick ratio of 0.71 and a debt-to-equity ratio of 0.56. The firm has a market capitalization of $232.29 billion, a price-to-earnings ratio of 24.29, a price-to-earnings-growth ratio of 1.39 and a beta of 0.75. UnitedHealth Group has a 52 week low of $170.25 and a 52 week high of $250.79.
UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, April 17th. The healthcare conglomerate reported $3.04 EPS for the quarter, topping analysts’ consensus estimates of $2.91 by $0.13. The company had revenue of $55.19 billion for the quarter, compared to analyst estimates of $54.90 billion. UnitedHealth Group had a return on equity of 22.06% and a net margin of 5.41%. The business’s revenue was up 13.3% on a year-over-year basis. During the same quarter in the previous year, the firm earned $2.37 earnings per share. research analysts anticipate that UnitedHealth Group will post 12.61 earnings per share for the current year.
In other UnitedHealth Group news, insider Larry C. Renfro sold 22,184 shares of the business’s stock in a transaction on Thursday, March 15th. The stock was sold at an average price of $228.94, for a total value of $5,078,804.96. Following the transaction, the insider now owns 173,229 shares of the company’s stock, valued at $39,659,047.26. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director Kenneth Irwin Shine sold 202 shares of the business’s stock in a transaction on Thursday, April 19th. The stock was sold at an average price of $237.42, for a total value of $47,958.84. Following the completion of the transaction, the director now directly owns 28,948 shares in the company, valued at approximately $6,872,834.16. The disclosure for this sale can be found here. In the last three months, insiders sold 72,019 shares of company stock worth $16,550,733. Insiders own 0.87% of the company’s stock.
UNH has been the topic of a number of research reports. Zacks Investment Research upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $267.00 price objective on the stock in a research report on Saturday, January 20th. Credit Suisse Group restated a “buy” rating on shares of UnitedHealth Group in a research report on Friday, March 9th. Morgan Stanley boosted their price objective on UnitedHealth Group from $275.00 to $277.00 and gave the company an “overweight” rating in a research report on Wednesday, April 18th. Barclays initiated coverage on UnitedHealth Group in a research report on Thursday, March 8th. They set an “overweight” rating and a $265.00 price objective on the stock. Finally, JPMorgan Chase boosted their price objective on UnitedHealth Group to $266.00 and gave the company an “overweight” rating in a research report on Wednesday, April 18th. Two analysts have rated the stock with a hold rating and twenty-six have issued a buy rating to the stock. The stock presently has an average rating of “Buy” and a consensus price target of $253.70.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.